Katja K.H. Aben

36.5k total citations · 2 hit papers
188 papers, 4.7k citations indexed

About

Katja K.H. Aben is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Katja K.H. Aben has authored 188 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Surgery, 62 papers in Pulmonary and Respiratory Medicine and 52 papers in Oncology. Recurrent topics in Katja K.H. Aben's work include Bladder and Urothelial Cancer Treatments (80 papers), Urinary and Genital Oncology Studies (53 papers) and Prostate Cancer Treatment and Research (34 papers). Katja K.H. Aben is often cited by papers focused on Bladder and Urothelial Cancer Treatments (80 papers), Urinary and Genital Oncology Studies (53 papers) and Prostate Cancer Treatment and Research (34 papers). Katja K.H. Aben collaborates with scholars based in Netherlands, United States and United Kingdom. Katja K.H. Aben's co-authors include Lambertus A. Kiemeney, Martine Ploeg, Anke Richters, J. Alfred Witjes, Nicholas G. Martin, Manuel Serrano‐Ríos, Aalt Bast, C L van Herwaarden, P. N. Richard Dekhuijzen and Mark Schoenberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Katja K.H. Aben

176 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The present and future burden of urinary bladder cancer in the world

2009 717 citations Katja K.H. Aben, Lambertus A. Kiemeney et al. World Journal of Urology profile →
The global burden of urinary bladder cancer: an update

2019 595 citations Anke Richters, Katja K.H. Aben et al. World Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katja K.H. Aben Netherlands	33	2.2k	1.1k	1.1k	1.1k	533	188	4.7k
Julio M. Pow‐Sang United States	38	1.7k 0.8×	1.3k 1.1×	1.1k 1.0×	1.3k 1.2×	506 0.9×	214	4.7k
Jonathan L. Wright United States	39	2.1k 1.0×	826 0.7×	1.1k 1.0×	2.0k 1.8×	620 1.2×	255	5.0k
Simon Tanguay Canada	40	2.1k 1.0×	816 0.7×	1.5k 1.4×	2.4k 2.2×	550 1.0×	213	4.7k
Swen‐Olof Andersson Sweden	34	1.3k 0.6×	1.3k 1.1×	698 0.6×	3.4k 3.2×	596 1.1×	59	5.6k
Benjamin L. Laskin United States	34	1.3k 0.6×	932 0.8×	750 0.7×	430 0.4×	427 0.8×	101	5.3k
Masaru Murai Japan	44	1.3k 0.6×	1.3k 1.2×	2.4k 2.2×	2.7k 2.5×	1.3k 2.4×	234	6.5k
Byong Chang Jeong South Korea	33	1.3k 0.6×	676 0.6×	1.2k 1.1×	2.3k 2.1×	476 0.9×	248	4.1k
Hyeon Hoe Kim South Korea	35	2.3k 1.0×	783 0.7×	973 0.9×	2.4k 2.2×	506 0.9×	295	4.9k
Alessandro Sciarra Italy	41	954 0.4×	775 0.7×	1.3k 1.2×	3.5k 3.2×	765 1.4×	250	6.6k
Tien C. Ko United States	41	1.9k 0.9×	1.2k 1.1×	1.3k 1.2×	616 0.6×	343 0.6×	166	5.0k

Countries citing papers authored by Katja K.H. Aben

Since Specialization

Citations

This map shows the geographic impact of Katja K.H. Aben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja K.H. Aben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja K.H. Aben more than expected).

Fields of papers citing papers by Katja K.H. Aben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja K.H. Aben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja K.H. Aben. The network helps show where Katja K.H. Aben may publish in the future.

Co-authorship network of co-authors of Katja K.H. Aben

This figure shows the co-authorship network connecting the top 25 collaborators of Katja K.H. Aben. A scholar is included among the top collaborators of Katja K.H. Aben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja K.H. Aben. Katja K.H. Aben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bangma, Chris H., Maarten J. Bijlsma, Alfons C.M. van den Bergh, et al.. (2025). External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study. BMC Cancer. 25(1). 149–149. 1 indexed citations

Richters, Anke, Heidi P. Fransen, Tineke J. Smilde, et al.. (2024). Guidelines versus real-world data in metastatic bladder cancer: A population-based study on first-line chemotherapy treatment patterns. Urologic Oncology Seminars and Original Investigations. 43(5). 328.e17–328.e24.

Hoogstraten, Lisa M.C. van, Sebastiaan Remmers, Jorg R. Oddens, et al.. (2024). Risk of progression in patients with primary T1 high grade non-muscle invasive bladder cancer – a contemporary cohort. European Urology Oncology. 8(2). 249–252. 1 indexed citations

Incrocci, Luca, et al.. (2024). The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer. Acta Oncologica. 63. 511–517. 1 indexed citations

Oerlemans, Simone, Nicole P. M. Ezendam, Marissa C. van Maaren, et al.. (2024). Development of a prediction model for clinically-relevant fatigue: a multi-cancer approach. Quality of Life Research. 34(1). 231–245. 1 indexed citations

Aben, Katja K.H., et al.. (2023). Health-related Quality of Life During the First 4 Years After Non–Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort. European Urology Oncology. 7(4). 829–837. 3 indexed citations

Schuurman, Melinda S., Brunolf W. Lagerveld, Harrie P. Beerlage, et al.. (2023). Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study. SHILAP Revista de lepidopterología. 4(4). 455–463. 5 indexed citations

Richters, Anke, Debbie Robbrecht, Richard P. Meijer, et al.. (2023). Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort. European Urology Open Science. 59. 50–54. 1 indexed citations

Aarts, Maureen J.B., Axel Bex, Haiko J. Bloemendal, et al.. (2023). The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs. BMC Cancer. 23(1). 648–648. 3 indexed citations

10.

Richters, Anke, et al.. (2022). Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry. World Journal of Urology. 40(9). 2275–2281. 4 indexed citations

11.

Westgeest, Hans M., Alfons J.M. van den Eertwegh, R. Jeroen A. van Moorselaar, et al.. (2021). Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands. Clinical Genitourinary Cancer. 20(1). 43–52. 2 indexed citations

12.

Bronkhorst, Ewald M., G.A.M. Krekels, Simone van der Geer, et al.. (2021). Predictors of surgical treatment burden, outcomes, and overall survival in older adults with basal cell carcinoma: Results from the prospective, multicenter BATOA cohort. Journal of the American Academy of Dermatology. 86(5). 1010–1019. 9 indexed citations

13.

Richters, Anke, Joost L. Boormans, Michiel S. van der Heijden, et al.. (2021). Overall survival of patients receiving cisplatin or carboplatin for primary metastatic urothelial carcinoma of the bladder: A contemporary Dutch nationwide cohort study. European Urology Open Science. 33. S391–S391. 1 indexed citations

14.

Sedelaar, J.P. Michiel, et al.. (2021). Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer – A multicenter population-based cohort study. Clinical Nutrition. 41(1). 131–143. 20 indexed citations

15.

Mark, Marianne van der, et al.. (2020). Trends in incidence and survival of upper Urinary Tract Urothelial Carcinoma (UTUC) diagnosed between 1993-2017 in the Netherlands: A study on 13,438 patients. European Urology Open Science. 19. e2186–e2187. 1 indexed citations

16.

Galesloot, Tessel E., et al.. (2019). Cigarette Smoking and the Risk of Cutaneous Melanoma: A Case-Control Study. Dermatology. 236(3). 228–236. 24 indexed citations

17.

Witjes, J. Alfred, et al.. (2019). The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life. BMJ Open. 9(10). e030396–e030396. 10 indexed citations

18.

Aben, Katja K.H., et al.. (2016). Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study. World Journal of Urology. 34(8). 1053–1060. 12 indexed citations

19.

González‐Sánchez, José Luis, et al.. (2008). Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain. Clinical Endocrinology. 70(3). 390–393. 42 indexed citations

20.

Aben, Katja K.H., J. Alfred Witjes, J.A.A.M. van Dijck, et al.. (2000). Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin. European Journal of Cancer. 36(18). 2385–2389. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact